Pain and Chemical Dependency Fathy Nasr
|
|
- Merilyn Robinson
- 5 years ago
- Views:
Transcription
1 Pain and Chemical Dependency Fathy Nasr WEB SITE: profathynasr.com
2 Opioid Receptors Adenosine Guanosine Inositol
3 PHAMACOTHERAPY, Step ladder Analgesic pyramids WHO Nociceptive Neuropathic Simple analgesics + Strong opioids Simple Analgesics + Weak opioids Simple Analgesics Adjuvant + Simple analgesics + Strong opioids Adjuvant + Simple Analgesics + Weak opioids Adjuvant + Simple Analgesics
4 WHO 3-Step Ladder 1 Mild Acetaminophen NSAIDs, ASA ± Adjuvants 2 Moderate Codeine Hydrocodone Oxycodone Dihydrocodeine Tramadol ± Adjuvants 3 Severe Morphine Hydromorphone Methadone Levorphanol Fentanyl Oxycodone ± Adjuvants
5 Mechanism of action in vitro The lower the K i value, the higher the affinity mu delta kappa NE 5-HT Tramadol M Morphine Tramadol has a much lower affinity for Opioids receptors than morphine, but, in contrast, additionally inhibits monoamine reuptake. Adapted from: Raffa RB. Am J Med 1996
6 Structural modifications of the morphine skeleton Objective: To separate analgesic activity and side effects by modification of the morphine N N N N N HO HO O O OH OH HO O CO 2 Et O HO N HO
7 Opioids insensitive pain 1. Consider Opioids for all patients with moderate or severe chronic pain but weigh the influences 2. Have no analgesic ceiling effect. 3. Problem of addiction: Presence of pain protects against addiction. Pain that does not respond progressively to increasing opioids dose: 1. Nerve compression or nerve destruction 2. Skeletal pain 3. Neuropathic pain
8 PAIN TREATMENT Analgesic Guideline: Stabilize with short-acting before longacting Utilize least invasive route possible: Oral route preferable; concentrate sublingually Trans cutaneous > subcutaneous > intravenous Converting from one opioid to another: Calculate equi analgesic dose Reduce by 30-50%(Renal, hepatic disease, Geriatric patients) 10% total daily dose as prn If >2 prn s /24 hours, increase baseline by 25-50% to calculate new baseline. 1-2 h for oral; min for parenteral,
9 Adverse effects Side effects are mainly: Constipation. 41% Nausea / vomiting. 32% Sedation / dizziness., mental clouding 29% Rash. Respiratory depression. Less common Sweating, Myoclonus Amenorrhea Itch Sexual dysfunction Urinary retention Headache
10 PAIN TREATMENT Anticipate Opioid Side Effects Constipation Prophylactic treatment better than prn Stool softener: Colace (docusate) Bowel Stimulants: Senokot (senna) Dulcolax (bisacodyl) Hyperosmolar: Lactulose, Miralax Oral naloxone,naltrexone (enteric opioid antagonist) Avoid bulk laxatives
11 PAIN TREATMENT Anticipate Opioids Side Effects Sedation, most common in opioid naïve Tolerance usually develops in hours Appears well before respiratory depression Decrease dose or increase interval Consider amphetamines Avoid naloxone if possible (withdrawal)
12 PAIN TREATMENT Special Situations Anxiety and depression Don t over-normalize or over-pathologize Usual treatments work Special role of dextro amphetamine Neuropathic pain Tricyclic antidepressants >> SSRI s Anticonvulsants Gabapentin, Pregabalin Mexiletine
13 Opioids rotation Respiratory depression Addiction 1].Change route of administration not drug. Oral and trans dermal preferred Oral transmucosal available for fentanyl, used for breakthrough pain Rectal route limited use Par enteral SQ and IV preferred and feasible for long-term therapy Epidural intra thecal generally preferred for long-term use 2].Change the drug PO/PR (mg) Analgesic SC/IV/IM (mg) 30 Morphine Hydromorphone Oxycodone - 20 Methadone 10 3].Active metabolites may contribute more to the analgesic effect of repeated doses than a single dose (Pethadine, Morphine, Methadone)
14 Acute pain: very unlikely Cancer pain : very unlikely Chronic nonmalignant pain: Opioid Therapy: Standard of Care 30-80% of cancer patients depending on stage 24-37% of addicts complains of chronic severe pain (Rosenblum et al, JAMA, 2003) Populations with advanced illness Cancer HIV/AIDS Others Moderate to severe pain Populations with acute illness, injury, or surgery 2-40% of general population (Gureje et al, JAMA, 1998; Verhaak et al, Pain, 1998) 30-40% overall, at least partially disabling in about 30% (Portenoy et al, J Pain, 2004)\ Short-term or long-term opioid therapy
15 Tolerance Is the need for higher dose( or increased plasma concentration) to achieve the same pharmacological effect.? Progress of disease rather than tolerance Declining effect with drug exposure Tolerance to side effects is desirable; tolerance to analgesia may be a problem Large clinical experience is reassuring Theoretical connection to the genesis of addiction/relapse, but neither necessary nor sufficient Should never be labeled addiction Problem of tolerance: Tolerance can be prevented or delayed if dosing is properly scheduled.
16 The 0pioid paradox The smart balance Sufficient Analgesia Tolerance Hypoventilation Reduced GIT motility (Ward,2002)
17 Opioid for Chronic Pain: The Need for Balance Opioids are essential drugs. Patients with pain, including those with addiction, must have access to treatment Opioids are abusable, particularly by those with addiction. Regulators and law enforcement must stem diversion and abuse
18 Opioids for Chronic Pain: Historical Context War on drugs Tragedy of needless pain
19 Definitions Abstinence Addiction Cross-addiction Neuroadaptation Opiophobia Physical dependence Poly substance related disorder Pseudo addiction Recovery Remission Substance abuse Substance dependence Withdrawal syndrome
20 Physical Dependence Potential for abstinence on abrupt discontinuation or dose reduction, or administration of an antagonist Highly variable phenomenology Tachycardia, tachypnea Nausea/vomiting, diarrhea, abdominal cramps Sweating, rhino rhea, piloerection Myalgias and arthralgias Anxiety, insomnia Not a problem if abstinence is avoided Theoretical connection to the genesis of addiction/relapse, but neither necessary nor sufficient Should never be labeled addiction
21 Substance abuse A maladaptive pattern of drug use that results in harm or places the individual at risk Using street drugs, non-medical sources, self escalation, use pain medication for other reason than to control pain Loss of control over drugs Drug use outside of socially accepted norms Includes any use of an illicit drug and some degree of aberrant use of prescription drugs DSM IV: Psychoactive Substance Abuse
22 Addiction Is a primary, chronic, neurobiological disease with genetic, psychosocial and environmental factors influencing its development and manifestation. Presence of pain protects against addiction. It is characterized by behaviors that include one or more of the following: 4C impaired control over drug use compulsive use continued use despite harm craving 3-26% general population 19-25% hospitalized patients 40-60% after major trauma 3-16% chronic pain patient( opiates) 70% 0f pain patient on Opioids
23 Pseudo addiction 1. Aberrant drug-related behavior in patients reacting to under treatment of pain. 2. Diagnostic challenge: May co-exist with addiction or other psychiatric disorders multiple providers, repeatedly requesting more medication Behavior disappears with proper treatment
24 Aberrant Drug-Related Behavior Problematic behaviors or red flags for clinicians Assessment: 1. History and physical examination 2. Diagnostic, therapeutic and laboratory results 3. Evaluations and consultations 4. Discussion of risks and benefits 5. Frequent visits. 6. Informed consent Treatment objectives: 1. Medications (including date, type, dose and quantity) 2. Prescription of long-acting drug only 3. Small prescription (one-week or two-week supply) Periodic reviews 1. Instructions and agreements, 2. Written agreement, perhaps a formal contract
25 Aberrant Drug-Related Behavior cont d Reporting unintended psychic effects Selling prescription drugs Prescription forgery Stealing or borrowing drug from another person Injecting oral formulation Obtaining prescriptions from non-medical source Multiple episodes of prescription loss Concurrent abuse of related illicit drugs Multiple dose escalations despite warnings Repeated gross impairment or dishevelment
26 Initial Structuring of Therapy to Reduce Risk Role of urine/blood drug screen Advantages Can confirm that prescribed drug is taken and that other drugs are not Makes a strong statement potentially useful in monitoring ( trust but verify ) Disadvantages Cannot confirm that the proper dose is taken Can be misinterpreted Can be stigmatizing
27 Opioid Therapy: Laws and Regulations International laws and treaties International Narcotics Control Board No direct influence on prescribers Federal laws and regulations FDA assesses safety and efficacy DEA monitors and addresses abuse/diversion State laws and regulations Medical boards and law enforcement Variable from state to state
28 Managing the patient Avoid IV, inhaled opiate( replace), prefer oral, rectal, topical, T. mucosal, T. dermal and long acting, implanted, intra thecal. Control over conc., dose, type of medication Methadone should be initiated, Continue methadone and document follow-up. Stigma of drug abuse 21% taking psychotropic drugs from their physician
29 Opioid Therapy: Monitoring Outcomes Assess the Seven A s over time 1. Assessment 2. Analgesia (pain relief) 3. Activities of daily living (physical and psychosocial functioning) 4. Adverse effects (side effects) 5. Aberrant drug-related behavior 6. Adherent to diagnosis 7. Action( managements)
30 CAGE questionnaire 2-4 positive answer of 4 Ought to cut People criticize you, annoyed Feel guilty Morning drink (eye opener)
31 PAIN TREATMENT, CONCLUSION Patients are expert about their own pain Pain can almost always be relieved For unrelieved moderate or severe pain: Follow WHO Pain Guidelines Baseline dose at proper interval PRN for breakthrough at 10-15% total dose Get help for difficult cases Pain or palliative care specialists
32 Pain and Chemical Dependency: Conclusions The complex interface between pain and chemical dependency extends from molecular biology to public policy From the clinical perspective, the issues surrounding long-term Opioid therapy are most significant Opioid therapy can be considered in all populations, including those with addictive disease Ability to treat problematic patients is seen as a continuum of skills
33 Pain and Chemical Dependency: Conclusions Safe and effective Opioid therapy requires Assessment and reassessment Skillful drug administration Knowledge of addiction medicine principles Documentation and communication
34 CASE PRESENTATION 75 year old woman with metastatic ovarian cancer Admitted for experimental chemotherapy Not ready for hospice Usual pain severe rated 8/10 Current medication, Percocet (5/325) 2 tabs q4h Why not just increase the dose of Percocet?
35 Using the Equi analgesic Table, calculate an equivalent amount of oral morphine to 2 Percocet (5/325) /4h; select a new baseline. A. 10 mg MS /4h atc B. 15 mg MS /4h at c C. 20 mg MS /6h atc D. 30 mg MS /6h atc E. I am not sure; I need help.
36 Using the Equi analgesic Table, calculate an equivalent amount of oral morphine to 2 Percocet (5/325) /4h; select a new baseline. 2 tabs Percocet /4h = 12 tabs/day 12 tabs x 5 mg oxycodone /tab = 60 mg/day 60 mg oxycodone = 90 mg oral morphine Increase baseline by ~1/3 (poorly controlled) but decrease by ~1/3 with med change 90 mg / 6 doses = 15 mg /4h oral morphine
37 Now, based on the 15 mg MS /4h atc dose, calculate the appropriate prn dose. A. 5 mg MS /1h prn B. 10 mg MS /1h prn C. 15 mg MS /2h prn D. 20 mg MS /4h prn E. I am not sure
38 Now, based on the 15 mg MS /4h atc dose, calculate the appropriate prn dose. 15 mg MS /4h = 90 mg MS per day PRN dose is 10% of total daily dose PRN interval for oral is /1-2h PRN is 10 mg /1h
39 Based on your intervention (15mg /4h atc), her average pain is down to 6/10. She has taken 6 additional prn doses of 10 mg each in 24 hours. Calculate a new baseline and prn. Baseline A. 20 mg MS /4h atc B. 25 mg MS /4h atc C. 30 mg MS /6h atc D. 40 mg MS /6h atc E. I still don t get it
40 Based on your intervention (15mg /4h atc), her average pain is down to 6/10. She has taken 6 additional prn doses of 10 mg each in 24 hours. Calculate a new baseline and prn. PRN A. 10 mg MS /1h prn B. 15 mg MS /1h pr n C. 20 mg MS /4h prn D. 25 mg MS /4h prn
41 Total daily dose is 90 mg + 60 prn = 150 mg New baseline is 150 / 6 doses = 25 mg /4h New prn is 10% of 150 mg = 15 mg q1h prn
42 On 25 mg MS /4h, her pain is now 3/10 on average. She has taken only 1 prn. Choose a long-acting morphine dose and prn. Total 24 hour atc dose is 150 mg MS Baseline 75 mg MS Contin bid (1-60 mg tab and 1-15 mg tab bid) PRN remains the same - 15 mg MSIR /1h prn (3cc of 5 mg/cc liquid or 15 mg MSIR tablet)
43 After 2 months of good pain control, enrolled in hospice, she develops acute back pain (10/10) and vomiting. Calculate an equal amount of parenteral morphine (increased by 1/3) and an hourly rate. A. 1 mg/hr B. 3 mg/h r C. 5 mg/hr D. 7 mg/hr E. I am not sure
44 Hospice, she develops acute back pain (10/10) and vomiting. Calculate an equal amount of parenteral morphine (increased by 1/3) and an hourly rate. 30 mg oral morphine = 10 mg of IV morphine Total dose of 150 mg po = 50 mg IV Increase by ~1/3 = total daily dose of 70 mg Divide by 24 to get an hourly rate = 3 mg/hr
45 Assuming a 3 mg/hour rate, now calculate a new prn morphine dose A. 3 mg /30 minutes prn B. 7 mg /30 minutes pr n C. 10 mg /2h prn D. 20 mg /2h prn E. This seems like too much medicine
46 Assuming a 3 mg/hour rate, now calculate a new prn morphine dose 3 mg/hr = 72 mg per day New PRN is 10% daily dose = 7 mg Parenteral interval is / minutes
47 SOME ADDITONAL QUESTIONS How frequently to re-evaluate the baseline? Are there upper limits to morphine dose? Additional diagnostic issues for her pain? Does the fact she is on hospice limit her treatment options for pain?
48 After several dose adjustments, and radiation therapy, her pain is 3-4 on average. Her morphine infusion is at 5 mg per hour, and she has taken one prn of 12 mg in the last 24 hours. She wants to go home off IV s. Calculate an equivalent dose of morphine concentrate (20 mg/cc). A. 1cc /2h atc B. 2cc /2h at c C. 3cc /4h atc D. 4cc /4h atc E. Lost again
49 Calculate an equivalent dose of morphine concentrate (20mg/cc). 5 mg/hr = 120 mg/day IV morphine 10 mg IV = 30 mg po morphine 120 mg IV = 360 mg po morphine 360 mg / 6 doses = 60 mg q4h 20 mg/cc ms concentrate = 3 cc q4h 10% of 360 = 36 mg /1h prn 36 mg = ~ 2 cc ms concentrate /1h prn
50 Summary Treat moderate to severe pain aggressively Baseline meds around the clock 10% total daily dose prn (/1-2h po/30-60 min IV) Adjust baseline upward daily, adding prn total Oral > trans cutaneous > subcutaneous > IV Reduce by 1/3 when changing meds Elderly, renal or hepatic disease: reduce doses! Under-treated pain has adverse consequences Get help if you need it!
51 Quinsy, Addiction
52 Thank you very much for you attention
Medication Use & Chronic Pain Control: Managing Tolerance, Dependence, Addiction & Aberrant Medication Taking Behavior
Medication Use & Chronic Pain Control: Managing Tolerance, Dependence, Addiction & Aberrant Medication Taking Behavior Ernest J Dole, PharmD, PhC, FASHP, BCPS, CDE Pharmaceutical Care Coordinator ABQ Health
More informationPALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST
PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted
More informationPain Management in Hospice and Palliative Care
Pain Management in Hospice and Palliative Care A Case-based Approach JoAnne Nowak, M.D. Merrimack Valley Hospice Revised November 2011 Objectives Use a case study approach to stimulate discussion and illustrate
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More informationPain Management Strategies Webinar/Teleconference
Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits
More informationBASICS OF OPIOID PRESCRIBING 10:30-11:45AM
PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA BASICS OF OPIOID PRESCRIBING 10:30-11:45AM ACPE UAN: 107-000-14-013-L01-P Activity Type: Application-Based 0.125 CEU/1.25hr Learning Objectives for Pharmacists:
More informationDisclosures. Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals
Anne F. Walsh, MSN, ANP BC, ACHPN, CWOCN Kathleen Broglio, MN, ANP BC, ACHPN, CPE Disclosures Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals
More informationHOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain
Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid
More informationOverview of Essentials of Pain Management. Updated 11/2016
0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.
More informationGUIDELINES AND AUDIT IMPLEMENTATION NETWORK
GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management
More informationE-Learning Module N: Pharmacological Review
E-Learning Module N: Pharmacological Review This Module requires the learner to have read Chapter 13 of the Fundamentals Program Guide and the other required readings associated with the topic. Revised:
More informationPain Management in the Hospital
E P E C O Pain Management in the Hospital Denise Waugh, MD FACEP FAAHPM Medical Director of Palliative Care Services Scott and White Healthcare 724-6859 Pain is a more terrible lord of mankind than even
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More informationSlide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists
Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics
More informationNarcotic Analgesics. Jacqueline Morgan March 22, 2017
Narcotic Analgesics Jacqueline Morgan March 22, 2017 Pain Unpleasant sensory and emotional experience with actual or potential tissue damage Universal, complex, subjective experience Number one reason
More information(30689) PROT Pain PCA Adult Patient Controlled Analgesia
Diagnosis Allergies Nursing Assess and Document PCA: 1. Assess and document pain rating, sedation level and respiratory rate every 2 hours; assess and document pain rating, sedation level and respiratory
More informationKnock Out Opioid Abuse in New Jersey:
Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids
More informationAnalgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015
Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationPain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD
Pain management Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD Case #1 61 yo man with history of Stage 3 colon cancer, s/p resection and adjuvant chemotherapy with FOLFOX
More informationPain is a more terrible Lord of mankind than even death itself.
CHRONIC OPIOID RX FOR NON-MALIGNANT PAIN Gerald M. Aronoff, M.D., DABPM Med. Dir., Carolina Pain Assoc Charlotte, North Carolina, USA Pain Pain is a more terrible Lord of mankind than even death itself.
More informationEquianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine
Equianalgesic Dosing: Making Opioid Interchange Easier Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine 1 Why Change Opioids? Side Effects Insufficient Pain
More informationOpioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory
Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine
More informationPrescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D
Prescription Pain Management University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D 2 Objectives Understand how to preform a pain assessment Know which medications
More informationAcute Pain NETP: SEPTEMBER 2013 COHORT
Acute Pain NETP: SEPTEMBER 2013 COHORT Pain & Suffering an unpleasant sensory & emotional experience associated with actual or potential tissue damage, or described in terms of such damage International
More informationCHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?
CHAMP: Bedside Teaching TREATING PAIN Stacie Levine MD Teaching Trigger: An older adult patient is identified as having pain. Clinical Question: What is the approach to treating pain in the aging adult
More informationChoose a category. You will be given the answer. You must give the correct question. Click to begin.
Instructions for using this template. Remember this is Jeopardy, so where I have written Answer this is the prompt the students will see, and where I have Question should be the student s response. To
More informationOptimizing Your Quality of Life During Cancer Treatment: Pain & Side Effect Management
Optimizing Your Quality of Life During Cancer Treatment: Pain & Side Effect Management Eric Roeland, MD GI Oncology Palliative Medicine Pancreatic Cancer Patient Tool Belt Chemotherapy Surgery Pain & Symptom
More informationSubstitution Therapy for Opioid Use Disorder The Role of Suboxone
Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM
More informationSCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults
SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults BACKGROUND The justification for developing these guidelines lies
More informationReview of Pain Management with Clinical and Regulatory Updates
Review of Pain Management with Clinical and Regulatory Updates Palliative Care Collaborative: 8 th Annual Regional Conference October 10, 2014 Michael Stellini, M.D.,M.S. Medical Director, Hospice and
More informationRELIEVING VIRGINIA S PAIN AND SUFFERING 3:45-4:45PM
PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA RELIEVING VIRGINIA S PAIN AND SUFFERING 3:45-4:45PM ACPE UAN: 107-000-14-016-L05-P Activity Type: Application-Based 0.1 CEU/1.0 hr Learning Objectives for
More informationNational Council on Patient Information and Education
National Council on Patient Information and Education You are not alone The type of pain that caused your doctor to prescribe a pain medicine for you can make you feel that you are different from everyone
More informationRule Governing the Prescribing of Opioids for Pain
Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This
More informationAcute pain management in opioid tolerant patients. Muhammad Laklouk
Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)
More informationFDA hormone replacement therapy Web site 6
TABLE OF CONTENTS Caring for pain at UIMCC 1-5 FDA hormone replacement therapy Web site 6 P&T Committee Formulary Action - September 2003 6 Caring for pain at UIMCC The International Association for the
More informationEvidence-based Best Practice in Pain Management
Foundations in Palliative Medicine Colorado, November 2017 Evidence-based Best Practice in Pain Management Sudy Jahangiri, MD Crystal Owens, MD Continuing Education Disclosures Approval Statement: The
More informationPAIN MANAGEMENT COMPETENCY
PAIN MANAGEMENT COMPETENCY What is pain? Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Pain is always subjective.
More informationBJF Acute Pain Team Formulary Group
Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution
More informationAmber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center
Pharmacologic Management of Pain Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Objectives Identify types of
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationNo Pain, No Gain Pharmacy Patient Pain Counseling Competition
No Pain, No Gain Pharmacy Patient Pain Counseling Competition Offered by the Maine Pharmacy Association as part of the 2010 MPA Fall Conference Sponsored by an educational grant by NASPA and Purdue Pharma,
More informationGuidelines for Management of Chronic Non- Malignant Pain
Page 1 of 6 home contents: site guidelines email En Français Search! Guidelines for Management of Chronic Non- Malignant Pain The College of Physicians and Surgeons recognizes the important role served
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More informationInterprofessional Webinar Series
Interprofessional Webinar Series Opioids in the Medically Ill: Principles of Administration Russell K. Portenoy, MD Chief Medical Officer MJHS Hospice and Palliative Care Director MJHS Institute for Innovation
More informationUpdate on Pain: Collaborative Care for the Complex Patient
Update on Pain: Collaborative Care for the Complex Patient Nirmala R. Abraham, MD Medical Director Sycamore Pain Management Center Kettering Health Network Objectives Standardized approach to patient care
More informationNEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES
NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.
More informationAssociate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008
Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 PAIN MECHANISMS Somatic Nociceptive Visceral Inflammatory response sensitizes
More informationGG&C Chronic Non Malignant Pain Opioid Prescribing Guideline
GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline Background Persistent pain is common, affecting around five million people in the UK. For many sufferers, pain can be frustrating and disabling,
More informationPain Assessment & Management. For General Nursing Orientation
Pain Assessment & Management For General Nursing Orientation April 2012 Overview Definition of pain Barriers to effective pain management Types of pain Objective pain assessment Approaches to management
More informationAn overview of Medication Assisted Treatment (MAT) and acute pain management on MAT
An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)
More informationJuly We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely, 7/14
July 2014 he Knowledge and Attitudes Survey Regarding Pain tool can be used to assess nurses and other professionals in your setting and as a pre and post test evaluation measure for educational programs.
More information1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective
Cancer Related Pain: Case-Based Pharmacology Jeannine M. Brant, PhD, APRN, AOCN Oncology Clinical Nurse Specialist Nurse Scientist Billings Clinic Conflicts of Interest Jeannine Brant has served on the
More informationWhat do they have in common?
What do they have in common? Opioid use in USA Approximately 9 million people on long term opioids Approximated 5 million people reporting non-medical use of opioids 1997: 96mg/person morphine eq dispensed
More informationOpioid Conversions Mixture of Science and Art
Opioid Conversions Mixture of Science and Art Matthew J. Pingree, MD Assistant Professor Division of Pain Medicine Physical Medicine and Rehabilitation and Anesthesiology Mayo Clinic, Rochester Pingree.Matthew@Mayo.edu
More informationCENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August
BRAND NAME Symproic GENERIC NAME Naldemedine MANUFACTURER Shionogi Inc. DATE OF APPROVAL March 23, 2017 PRODUCT LAUNCH DATE Anticipated to launch mid-summer 2017 REVIEW TYPE Review type 1 (RT1): New Drug
More informationAcute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX
Acute Pain Management in the Hospital Setting Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX 2 What is Pain? An unpleasant sensory and emotional experience associated
More informationMichael O Neil, Pharm.D. Professor and Vice-Chair, Department of Pharmacy Practice Drug Diversion, Substance Abuse, and Pain Management Consultant
Michael O Neil, Pharm.D. Professor and Vice-Chair, Department of Pharmacy Practice Drug Diversion, Substance Abuse, and Pain Management Consultant South College School of Pharmacy Knoxville, TN (304) 546-7746
More informationCLINICAL POLICY DEPARTMENT: Medical
IMPTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of currently available generally
More informationThe pain of it all. Rod MacLeod MNZM. Hibiscus Hospice, Auckland and University of Auckland
The pain of it all Rod MacLeod MNZM Hibiscus Hospice, Auckland and University of Auckland Definition of PAIN An unpleasant sensory and emotional experience which we primarily associate with tissue damage
More informationPain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017
Pain management in Paediatric Palliative Care Dr Jane Nakawesi 14 th August 2017 Content Management of pain in children Non pharmacological Pharmacological Exit level outcomes The participants will: Know
More informationA. The treatment of pain is controversial, frequently difficult and often the source of much frustration for both the physician and the patient.
I. INTRODUCTION. A. The treatment of pain is controversial, frequently difficult and often the source of much frustration for both the physician and the patient. B. This pamphlet attempts to explain the
More informationOpioids: Safe Use and Side Effects
Opioids: Safe Use and Side Effects Your doctor has prescribed an opioid (OHpee-oyd). This drug can control moderate to severe pain without increased risk of bleeding and kidney problems. Always take the
More information10/08/59 PAIN IS THE MOST COMMON TREATABLE SYMPTOM OF CANCER CURRENT EVIDENCE BASED CONCEPTS: MANAGEMENT OF CANCER PAIN PAIN AN UNMET CLINICAL NEED IN
Pain is a frequent complication of cancer, and is common in many other life-limiting illnesses MANAGEMENT OF CANCER PAIN A/Prof Ghauri Aggarwal FRACP, FAChPM, FFPMANZCA Palliative Medicine Physician Sydney
More informationSafe Opioid Prescribing Practices in the Elderly
Safe Opioid Prescribing Practices in the Elderly Masil George, MD Director, Geriatric Palliative Care Program Medical Director, Baptist Hospice This program has been funded under grant #U1QHP28723 No financial
More informationUniversal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?
Learning objectives 1. Identify the contribution of psychosocial and spiritual factors to pain 2. Incorporate strategies for identifying and mitigating opioid misuse 3. Incorporate non-pharmaceutical modalities
More informationIntractable pain syndrome is defined as persistent pain despite all the reasonable efforts to treat.
Difficult Pain Syndrome/Intractable/Refractory Pain Intractable pain syndrome is defined as persistent pain despite all the reasonable efforts to treat. Reasonable efforts Differs for specialties/regions/countries
More information6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages
Nalbuphine: Analgesic with a Niche Mellar P Davis MD FCCP FAAHPM 1 Summary of Advantages Safe in renal failure- fecal excretion Analgesia equal to morphine with fewer side effects Reduced constipation
More informationAnalgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-
Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the
More informationOpioid Case Studies. Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN. September 29, MFMER slide-1
Opioid Case Studies Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN September 29, 2016 2015 MFMER slide-1 Disclosures Relevant Financial Relationship(s) None Off Label and/or
More informationObjectives: What is your Definition of Pain? 8/16/2017
Safe Opioid Management for the Seriously Ill Patient Sam Perna, D.O. Objectives: MDB1 1) Participants will understand the way the body s pain system works. 2) Participants will identify the elements of
More informationFighting the Good Fight: How to Convert Opioids Just Right!
Fighting the Good Fight: How to Convert Opioids Just Right! Tanya J. Uritsky, PharmD, BCPS, CPE Clinical Pharmacy Specialist - Pain Medication Stewardship Hospital of the University of Pennsylvania - Philadelphia,
More informationPAIN MANAGEMENT 101. By: Vicki McCulloch RN, NP & DeAnna Looper RN, CHPN, CHPCA
PAIN MANAGEMENT 101 By: Vicki McCulloch RN, NP & DeAnna Looper RN, CHPN, CHPCA Objectives Identify a step-wise approach to pain management. Identify the WHO Pain Ladder. Identify non-pharmacological pain
More informationOpioid Pain Management. John Manfredonia, DO. Disclosures. Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare
Opioid Pain Management John Manfredonia, DO Disclosures Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare VistaCare has provided commercial support for this activity Palliative
More informationOpioids and adjuvant analgesics in palliative care
Opioids and adjuvant analgesics in palliative care Amy Allen Case MD, FAAHPM Supportive Care Department Chair, Palliative Care Program Chief Roswell Park Cancer Institute Associate Professor of Medicine
More informationPain Management in Medical Dermatology
Pain Management in Medical Dermatology Robert G. Micheletti, MD Assistant Professor of Dermatology and Medicine Director, Cutaneous Vasculitis Clinic, Penn Vasculitis Center Co-Director, Inpatient Dermatology
More informationCDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control
CDC Guideline for Prescribing Opioids for Chronic Pain Centers for Disease Control and Prevention National Center for Injury Prevention and Control THE EPIDEMIC Chronic Pain and Prescription Opioids 11%
More informationOpioid Pearls and Acute Pain Management
Opioid Pearls and Acute Pain Management Jeanie Youngwerth, MD University of Colorado Denver Assistant Professor of Medicine, Hospitalist Associate Director, Colorado Palliative Medicine Fellowship Program
More informationCanadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain
Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program New Glasgow November 1, 2017 This speaker has been asked to disclose to the audience any involvement with
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationPalliative and Hospice Care of the Terminally Ill Introduction
Palliative and Hospice Care of the Terminally Ill Introduction There has been an increase in life expectancy for men and women of all races to 77.6 years Leading causes of death in older patients are chronic
More informationSession II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids
Learning Objectives for Session II Session II Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between Upon completion of this module, the participants will be
More informationNew Guidelines for Prescribing Opioids for Chronic Pain
New Guidelines for Prescribing Opioids for Chronic Pain Andrew Lowe, Pharm.D. CAPA Meeting October 6, 2016 THE EPIDEMIC Chronic Pain and Prescription Opioids 11% of Americans experience daily (chronic)
More informationPAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC
PAIN MANAGEMENT PGY-1 Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC Perception Matters A builder aged 29 came to the accident and emergency
More informationManaging Care at End of Life:
Managing Care at End of Life: Physical Suffering Pain & Dyspnea Verna Sellers, MD, MPH, AGSF Medical Director Centra PACE Lynchburg, Virginia 1 Speaker Disclosures: Dr. Sellers has disclosed that she has
More informationOAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM
OAT Transitions - focus on microdosing Mark McLean MD MSc FRCPC CISAM DABAM Disclosures No pharmaceutical industry or other financial conflicts of interest Study Physician for research funded by Canadian
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationSymptom Management Challenges at End-of-Life
Symptom Management Challenges at End-of-Life Amanda Lovell, PharmD, BCGP Clinical Pharmacist- Inpatient Units Optum Hospice Pharmacy Services February 15, 2018 Hospice Pharmacy Services Objectives Identify
More informationPain Management: Overview of A Practical Approach
Pain Management: Overview of A Practical Approach Michael B. Potter, M.D. Department of Family and Community Medicine University of California, San Francisco What is Pain? An unpleasant sensory and emotional
More informationSubject: Pain Management (Page 1 of 7)
Subject: Pain Management (Page 1 of 7) Objectives: Managing pain and restoring function are basic goals in helping a patient with chronic non-cancer pain. Federal and state guidelines require that all
More informationOPIOIDS AND NON-CANCER PAIN
Ch05.qxd 1/6/04 4:33 PM Page 77 CHAPTER 5 OPIOIDS AND NON-CANCER PAIN Background 78 Side-effects of opioids 78 Tolerance, physical dependence and addiction 79 Opioid-induced pain 79 Practical issues 80
More informationBuprenorphine pharmacology
Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely
More informationAETNA BETTER HEALTH Prior Authorization guideline for Narcotic Analgesic Utilization
AETNA BETTER HEALTH Prior Authorization guideline for Narcotic Analgesic Utilization Policy applies to all formulary and non-formulary schedules II V opioid narcotics, including tramadol and codeine, as
More informationObjectives. Controversy. Pain. Risk Stratification 1/7/2012
Objectives Strategies in Pain Management: Scheduled, Breakthrough, and Dose Adjustments Tamara M. Green, Pharm.D PGY-1 Resident Florida A & M University Classify and distinguish between different types
More informationChronic Non Malignant Pain Opioid Guideline
CLINICAL GUIDELINE Chronic Non Malignant Pain Opioid Guideline A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised
More informationTips for Managing Acute Pain
Tips for Managing Acute Pain Daniel Johnson, MD, FAAHPM Kaiser Permanente University of Colorado Session Outline 1. Pseudoaddiction 2. Opioid Selection 3. PCA Titration 4. Co-Analgesics 5. Breakthrough
More informationTapering Opioids Best Practices*
Tapering Opioids Best Practices* Chuck Hofmann, MD, MACP 5 th Annual EOCCO Office Staff and Provider Summit September 28, 2017 Disclosure No Conflicts of Interest to report Learning Objectives Understand
More informationPAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationModule 2 Pain Management. Handouts. Pain Is... Please click the links button under the video. You can print and/or save the handouts.
E L N E C End-of-Life Nursing Education Consortium SuperCore Curriculum Module 2 Pain Management Handouts Please click the links button under the video. You can print and/or save the handouts. Pain Is...
More informationPalliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015
Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015 Objectives Define palliative care and primary palliative care Describe the rationale for providing primary palliative care in
More information